CytoAgents is Emergex Vaccines's #1 rival. CytoAgents was founded in 2018 in Pittsburgh, Pennsylvania. Like Emergex Vaccines, CytoAgents also operates in the Biotechnology space. CytoAgents generates $2.5M less revenue than Emergex Vaccines.
Antios is one of Emergex Vaccines's top competitors. Antios is headquartered in Mendham, New Jersey, and was founded in 2018. Like Emergex Vaccines, Antios also works within the Pharmaceuticals & Biotechnology sector. Antios generates 85% the revenue of Emergex Vaccines.
Hookipa Pharma is seen as one of Emergex Vaccines's top competitors. Hookipa Pharma was founded in 2011, and its headquarters is in New York, New York. Like Emergex Vaccines, Hookipa Pharma also works within the Biotechnology sector. Hookipa Pharma has 143 more employees than Emergex Vaccines.